Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Antal

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
The Journal of Clinical Psychiatry|October 1, 1988
Clinical outcome and adverse effect profile associated with concurrent administration of alprazolam and imipramineB G Wells, R L Evans, L Ereshefsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effectsR M Bukowski, G T Budd, J A Gibbons, et al.
Cancer Research|February 1, 1991
Induction of cytokine messenger RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving granulocyte-macrophage colony-stimulating factor therapyM J Thomassen, M Ahmad, B P Barna, et al.
Clinical Pharmacology and Therapeutics|July 17, 2007
Pharmacometrics and the transition to model-based developmentT H Grasela, C W Dement, O G Kolterman, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|May 1, 1996
Alcohol dependence: is carbohydrate-deficient transferrin a marker for alcohol intake?O M Lesch, H Walter, J Antal, et al.
Clinical Pharmacology and Therapeutics|August 1, 1992
Pharmacokinetics and pharmacodynamics of oral diazepam: effect of dose, plasma concentration, and timeH Friedman, D J Greenblatt, G R Peters, et al.
Journal of Clinical Pharmacology|February 11, 2005
CYP3A and P-glycoprotein activity induction with St. John's Wort in healthy volunteers from 6 ethnic populationsRujia Xie, Lai Hock Tan, Emery C Polasek, et al.
Journal of Clinical Psychopharmacology|February 1, 1990
The relationship of alprazolam dose to steady-state plasma concentrationsD A Ciraulo, E J Antal, R B Smith, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
The Journal of Clinical Psychiatry|October 1, 1988
Clinical outcome and adverse effect profile associated with concurrent administration of alprazolam and imipramineB G Wells, R L Evans, L Ereshefsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effectsR M Bukowski, G T Budd, J A Gibbons, et al.
Cancer Research|February 1, 1991
Induction of cytokine messenger RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving granulocyte-macrophage colony-stimulating factor therapyM J Thomassen, M Ahmad, B P Barna, et al.
Clinical Pharmacology and Therapeutics|July 17, 2007
Pharmacometrics and the transition to model-based developmentT H Grasela, C W Dement, O G Kolterman, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|May 1, 1996
Alcohol dependence: is carbohydrate-deficient transferrin a marker for alcohol intake?O M Lesch, H Walter, J Antal, et al.
Clinical Pharmacology and Therapeutics|August 1, 1992
Pharmacokinetics and pharmacodynamics of oral diazepam: effect of dose, plasma concentration, and timeH Friedman, D J Greenblatt, G R Peters, et al.
Journal of Clinical Pharmacology|February 11, 2005
CYP3A and P-glycoprotein activity induction with St. John's Wort in healthy volunteers from 6 ethnic populationsRujia Xie, Lai Hock Tan, Emery C Polasek, et al.
Journal of Clinical Psychopharmacology|February 1, 1990
The relationship of alprazolam dose to steady-state plasma concentrationsD A Ciraulo, E J Antal, R B Smith, et al.
Pageof 11